Lorna Warwick is CEO of the Lymphoma Coalition, a worldwide network of patient groups with a full or partial focus on providing support to patients with lymphoma. In this wide-ranging interview, Warwick highlights the progress made in lymphoma treatment in recent years and the work still to be done to better integrate authentic patient experiences and insights into the drug development, regulation, and assessment processes, especially for cutting-edge therapies such as CAR-T.
CAR-T, which was touted as a game-changing curative treatment, has been the answer for some patients, but not all
